StonvexLoading…
StonvexStonvexStonvexCore line items from CBRL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-08-01 | Annual 2024 2024-08-02 | Annual 2023 2023-07-28 | Annual 2022 2022-07-29 |
|---|---|---|---|---|
Revenue | $3.48B | $3.47B | $3.44B | $3.27B |
Operating Income | $55.03M | $45.12M | $120.62M | $153.00M |
Net Income | $46.38M | $40.93M | $99.05M | $131.88M |
EPS (Diluted) | $2.06 | $1.83 | $4.45 | $5.67 |
Total Assets | $2.16B | $2.16B | $2.22B | $2.29B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $39.64M | $12.04M | $25.15M | $45.10M |
Free Cash Flow OCF − CapEx | $59.76M | $40.69M | $123.47M | $106.91M |
Shares Outstanding | 22.27M | 22.20M | 22.15M | 22.28M |